ATROSAB

ATROSAB is a new generation humanised antibody specifically binding the TNF receptor 1. ATROSAB can be used for therapy of rheumatoid arthritis, inflammatory bowel disease, Crohn’s disease, Colitis Ulcerosa, Psoriasis and inflammation e.g. sepsis. Potency in therapy of acute inflammatory diseases has already been proven in animal models.